Advertisement.

DERM Projected Dividend Yield

Journey Medical Corp ( NASDAQ : DERM )

Journey Medical is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Co.'s portfolio includes five branded and three authorized generic prescription drugs. Co.'s marketed products include: Qbrexza®, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane®, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Targadox®, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino®, an oral minocycline drug for the treatment of acne; and Exelderm® Cream and Solution, an antifungal intended for topical use.

20 YEAR PERFORMANCE RESULTS

DERM Dividend History Detail
DERM Dividend News
DERM Competitors News

# of Shares: 0

Closing Price: 3.45

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000